<p>ICU Medical, Inc. (納斯達克股票代碼:ICUI) 在九月份看到了空頭頭寸大幅下降。截至 9 月 15 日，空頭頭寸總計為 831,100 股，較 8 月 31 日的 924,500 股下降了 10.1%。目前，公司股份中有 3.7% 被空頭賣空。根據平均每日交易量為 337,000 股，目前的天數覆蓋率為 2.5 天。</p>
<h2>華爾街分析師預測增長</h2>
<p>多位研究分析師對 ICUI 股票發表了看法。Needham &amp; Company LLC 在 8 月 8 日星期四的研究報告中重申了對 ICU Medical 股票的&#34;持有&#34;評級。KeyCorp 將 ICU Medical 的目標股價從 136.00 美元上調至 147.00 美元，並在 8 月 8 日星期四的研究報告中給予公司&#34;超重&#34;評級。Raymond James 將 ICU Medical 的目標股價從 158.00 美元上調至 190.00 美元，並在 9 月 12 日星期四的研究報告中給予公司&#34;表現優異&#34;評級。最後，StockNews.com 在 9 月 12 日星期四的研究報告中將 ICU Medical 股票的評級從&#34;持有&#34;上調至&#34;買入&#34;。一位投資分析師對該股票給予持有評級，四位分析師給予公司股票買入評級。根據 MarketBeat.com 的數據，ICU Medical 的共識評級為&#34;中等買入&#34;，平均目標股價為 149.00 美元。</p>
<p><strong>閲讀我們關於 ICUI 的最新股票報告</strong></p>
<h2>ICU Medical 內部交易</h2>
<p>另外，副總裁 Daniel Woolson 於 8 月 30 日星期五進行了一筆交易，賣出了 ICU Medical 股票的 2,502 股。這些股票的平均價格為 163.22 美元，交易總額為 408,376.44 美元。交易完成後，該副總裁現在持有公司的 13,107 股股份，價值約 2,139,324.54 美元。該交易已在提交給美國證券交易委員會（SEC）的文件中披露，可以通過此鏈接訪問。此外，副總裁 Daniel Woolson 於 8 月 30 日星期五進行了一筆交易，賣出了公司股票的 2,502 股。這些股票的平均價格為 163.22 美元，交易總額為 408,376.44 美元。交易完成後，該副總裁現在持有公司的 13,107 股股份，價值 2,139,324.54 美元。該交易已在提交給 SEC 的文件中披露，可以通過 SEC 網站訪問。此外，副總裁 Virginia Ruth Sanzone 於 8 月 8 日星期四進行了一筆交易，賣出了公司股票的 2,050 股。這些股票的平均價格為 144.11 美元，交易總額為 295,425.50 美元。交易完成後，該副總裁現在持有公司的 4,482 股股份，價值約 645,901.02 美元。此次交易的披露可以在此處找到。內部人士在上一季度共出售了價值 4,537,802 美元的公司股票總計 28,552 股。公司股份的 6.70% 歸內部人士所有。</p>
<h2>對 ICU Medical 的對沖基金看法</h2>
<p>機構投資者和對沖基金最近調整了他們對該股票的持股。Scout Investments Inc.在第一季度將其對 ICU Medical 的持股增加了 16.3%。Scout Investments Inc.現在擁有 51,819 股 ICU Medical 的股份，價值 5,463,000 美元，比上一季度增加了 7,272 股。Wakefield Asset Management LLLP 在第一季度收購了 ICU Medical 的新頭寸，價值 989,000 美元。Vanguard Group Inc.在第四季度將其對 ICU Medical 的持股增加了 14.8%。Vanguard Group Inc.現在擁有 2,440,729 股 ICU Medical 的股份，價值 243,438,000 美元，比上一季度增加了 315,103 股。SG Americas Securities LLC 在第二季度將其對 ICU Medical 的持股增加了 441.7%。SG Americas Securities LLC 現在擁有 5,818 股 ICU Medical 的股份，價值 691,000 美元，比上一季度增加了 4,744 股。最後，Sei Investments Co.在第一季度將其對 ICU Medical 的持股增加了 52.1%。Sei Investments Co.現在擁有 28,586 股 ICU Medical 的股份，價值 3,068,000 美元，比上一季度增加了 9,793 股。目前，該股票的 96.10% 由機構投資者和對沖基金持有。</p>
<h2>ICU Medical 股價下跌 0.0%</h2>
<p>ICUI 股票在週五交易中下跌 0.01 美元，收於 174.47 美元。公司股票的交易量為 177,791 股，相比平均交易量 280,425 股有所下降。該公司的五十日移動平均股價為 154.77 美元，兩百日移動平均股價為 124.01 美元。公司的速動比率為 1.08，流動比率為 2.41，負債權益比為 0.76。該公司的市值為 42.5 億美元，市盈率為-71.21，貝塔係數為 0.65。ICU Medical 的一年最低股價為 78.28 美元，最高股價為 181.87 美元。</p>
<p>ICU Medical (納斯達克股票代碼:ICUI) 在 8 月 7 日星期三發佈了其最新的財報。這家醫療器械供應商報告稱，該季度每股收益為 1.56 美元，超過分析師預期的 1.00 美元 0.56 美元。該季度營收為 5.965 億美元，超過市場預期的 5.5664 億美元。ICU Medical 的淨利潤率為-3.07%，股東權益回報率為 5.01%。公司當季營收同比增長了 8.6%。在去年同期，公司每股收益為 1.58 美元。分析師預計 ICU Medical 今年將實現每股盈利 3.76 美元。</p>
<h2>關於 ICU Medical（獲取免費報告）</h2>
<p>ICU 醫療公司及其子公司在全球範圍內開發、製造和銷售用於輸液治療、血管通路和重要護理應用的醫療器械。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢裝置；ChemoClave 和 ChemoLock 封閉系統轉移裝置，用於限制有害藥物或蒸氣濃度的泄漏，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 用於門靜脈通路的非穿刺針；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>閲讀更多</h2>
<ul>
<li>我們喜歡的五隻股票勝過 ICU 醫療</li>
<li>選舉股票：選舉如何影響股市</li>
<li>西蒙地產房地產投資信託：增長和穩定股息的安全選擇</li>
<li>如何確定要購買哪種加密貨幣：投資者指南</li>
<li>CarMax 令人印象深刻的漲勢：投資者應該關注什麼</li>
<li>哪些華爾街分析師最準確？</li>
<li>MarketBeat 周評 – 9/23 - 9/27</li>
</ul>
<p><em>這則即時新聞警報是由敍事科技和 MarketBeat 的金融數據生成，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊的審核。請將有關本故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<p>→ 注意：您有時間直到 11 月 19 日星期二（來自市場幕後）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw"/></p>
<h2>您現在是否應該投資 1,000 美元購買 ICU 醫療股票？</h2>
<p>在考慮購買 ICU 醫療股票之前，您應該聽聽這個。</p>
<p>MarketBeat 追蹤華爾街評級最高且表現最佳的研究分析師以及他們每天向客户推薦的股票。MarketBeat 已確定了五隻頂級分析師悄悄告訴客户現在購買的股票清單... 而 ICU 醫療並不在其中。</p>
<p>儘管 ICU 醫療目前在分析師中具有 “中等買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

ICU醫療

<p>ICU 醫療（NASDAQ:ICUI）在九月份空頭頭寸下降了 10.1%，截至 9 月 15 日，空頭售出了 831,100 股股票。這一數字較 8 月底的 924,500 股有所下降。目前的空頭頭寸比率為 2.5 天，佔公司股份的 3.7%。分析師對該股票的評級褒貶不一，其中一家持有評級，四家持有買入評級，共識評級為 “中等買入”。內部人士在上個季度共售出了 28,552 股股票，而機構投資者持有該股票的比例為 96.10%</p>

<p>ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) saw a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 831,100 shares, a decline of 10.1% from the August 31st total of 924,500 shares. Currently, 3.7% of the company's shares are short sold. Based on an average daily trading volume, of 337,000 shares, the days-to-cover ratio is currently 2.5 days.</p>
<div class="lb-trans"><p>ICU Medical, Inc. (納斯達克股票代碼:ICUI) 在九月份看到了空頭頭寸大幅下降。截至 9 月 15 日，空頭頭寸總計為 831,100 股，較 8 月 31 日的 924,500 股下降了 10.1%。目前，公司股份中有 3.7% 被空頭賣空。根據平均每日交易量為 337,000 股，目前的天數覆蓋率為 2.5 天。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>A number of research analysts have weighed in on ICUI shares. Needham &amp; Company LLC reaffirmed a &#34;hold&#34; rating on shares of ICU Medical in a research note on Thursday, August 8th. KeyCorp lifted their price target on shares of ICU Medical from $136.00 to $147.00 and gave the company an &#34;overweight&#34; rating in a research note on Thursday, August 8th. Raymond James lifted their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, September 12th. Finally, StockNews.com raised shares of ICU Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Thursday, September 12th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, ICU Medical has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $149.00.</p>
<div class="lb-trans"><p>多位研究分析師對 ICUI 股票發表了看法。Needham &amp; Company LLC 在 8 月 8 日星期四的研究報告中重申了對 ICU Medical 股票的&#34;持有&#34;評級。KeyCorp 將 ICU Medical 的目標股價從 136.00 美元上調至 147.00 美元，並在 8 月 8 日星期四的研究報告中給予公司&#34;超重&#34;評級。Raymond James 將 ICU Medical 的目標股價從 158.00 美元上調至 190.00 美元，並在 9 月 12 日星期四的研究報告中給予公司&#34;表現優異&#34;評級。最後，StockNews.com 在 9 月 12 日星期四的研究報告中將 ICU Medical 股票的評級從&#34;持有&#34;上調至&#34;買入&#34;。一位投資分析師對該股票給予持有評級，四位分析師給予公司股票買入評級。根據 MarketBeat.com 的數據，ICU Medical 的共識評級為&#34;中等買入&#34;，平均目標股價為 149.00 美元。</p>
</div><p><strong>Read Our Latest Stock Report on ICUI</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 ICUI 的最新股票報告</strong></p>
</div><h2>Insider Transactions at ICU Medical</h2>
<div class="lb-trans"><h2>ICU Medical 內部交易</h2>
</div><p>In other news, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, VP Daniel Woolson sold 2,502 shares of the business's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares in the company, valued at $2,139,324.54. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the business's stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the transaction, the vice president now owns 4,482 shares of the company's stock, valued at approximately $645,901.02. The disclosure for this sale can be found here. Insiders sold a total of 28,552 shares of company stock worth $4,537,802 in the last quarter. 6.70% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>另外，副總裁 Daniel Woolson 於 8 月 30 日星期五進行了一筆交易，賣出了 ICU Medical 股票的 2,502 股。這些股票的平均價格為 163.22 美元，交易總額為 408,376.44 美元。交易完成後，該副總裁現在持有公司的 13,107 股股份，價值約 2,139,324.54 美元。該交易已在提交給美國證券交易委員會（SEC）的文件中披露，可以通過此鏈接訪問。此外，副總裁 Daniel Woolson 於 8 月 30 日星期五進行了一筆交易，賣出了公司股票的 2,502 股。這些股票的平均價格為 163.22 美元，交易總額為 408,376.44 美元。交易完成後，該副總裁現在持有公司的 13,107 股股份，價值 2,139,324.54 美元。該交易已在提交給 SEC 的文件中披露，可以通過 SEC 網站訪問。此外，副總裁 Virginia Ruth Sanzone 於 8 月 8 日星期四進行了一筆交易，賣出了公司股票的 2,050 股。這些股票的平均價格為 144.11 美元，交易總額為 295,425.50 美元。交易完成後，該副總裁現在持有公司的 4,482 股股份，價值約 645,901.02 美元。此次交易的披露可以在此處找到。內部人士在上一季度共出售了價值 4,537,802 美元的公司股票總計 28,552 股。公司股份的 6.70% 歸內部人士所有。</p>
</div><h2>Hedge Funds Weigh In On ICU Medical</h2>
<div class="lb-trans"><h2>對 ICU Medical 的對沖基金看法</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Scout Investments Inc. increased its holdings in shares of ICU Medical by 16.3% in the first quarter. Scout Investments Inc. now owns 51,819 shares of the medical instruments supplier's stock valued at $5,463,000 after purchasing an additional 7,272 shares during the last quarter. Wakefield Asset Management LLLP acquired a new position in shares of ICU Medical in the first quarter valued at $989,000. Vanguard Group Inc. increased its holdings in shares of ICU Medical by 14.8% in the fourth quarter. Vanguard Group Inc. now owns 2,440,729 shares of the medical instruments supplier's stock valued at $243,438,000 after purchasing an additional 315,103 shares during the last quarter. SG Americas Securities LLC increased its holdings in shares of ICU Medical by 441.7% in the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after purchasing an additional 4,744 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in shares of ICU Medical by 52.1% in the first quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier's stock valued at $3,068,000 after purchasing an additional 9,793 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近調整了他們對該股票的持股。Scout Investments Inc.在第一季度將其對 ICU Medical 的持股增加了 16.3%。Scout Investments Inc.現在擁有 51,819 股 ICU Medical 的股份，價值 5,463,000 美元，比上一季度增加了 7,272 股。Wakefield Asset Management LLLP 在第一季度收購了 ICU Medical 的新頭寸，價值 989,000 美元。Vanguard Group Inc.在第四季度將其對 ICU Medical 的持股增加了 14.8%。Vanguard Group Inc.現在擁有 2,440,729 股 ICU Medical 的股份，價值 243,438,000 美元，比上一季度增加了 315,103 股。SG Americas Securities LLC 在第二季度將其對 ICU Medical 的持股增加了 441.7%。SG Americas Securities LLC 現在擁有 5,818 股 ICU Medical 的股份，價值 691,000 美元，比上一季度增加了 4,744 股。最後，Sei Investments Co.在第一季度將其對 ICU Medical 的持股增加了 52.1%。Sei Investments Co.現在擁有 28,586 股 ICU Medical 的股份，價值 3,068,000 美元，比上一季度增加了 9,793 股。目前，該股票的 96.10% 由機構投資者和對沖基金持有。</p>
</div><h2>ICU Medical Stock Down 0.0 %</h2>
<div class="lb-trans"><h2>ICU Medical 股價下跌 0.0%</h2>
</div><p>Shares of ICUI stock traded down $0.01 during trading on Friday, reaching $174.47. The company's stock had a trading volume of 177,791 shares, compared to its average volume of 280,425. The business has a fifty day moving average price of $154.77 and a 200-day moving average price of $124.01. The company has a quick ratio of 1.08, a current ratio of 2.41 and a debt-to-equity ratio of 0.76. The company has a market cap of $4.25 billion, a price-to-earnings ratio of -71.21 and a beta of 0.65. ICU Medical has a one year low of $78.28 and a one year high of $181.87.</p>
<div class="lb-trans"><p>ICUI 股票在週五交易中下跌 0.01 美元，收於 174.47 美元。公司股票的交易量為 177,791 股，相比平均交易量 280,425 股有所下降。該公司的五十日移動平均股價為 154.77 美元，兩百日移動平均股價為 124.01 美元。公司的速動比率為 1.08，流動比率為 2.41，負債權益比為 0.76。該公司的市值為 42.5 億美元，市盈率為-71.21，貝塔係數為 0.65。ICU Medical 的一年最低股價為 78.28 美元，最高股價為 181.87 美元。</p>
</div><p>ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.00 by $0.56. The business had revenue of $596.50 million for the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The firm's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.58 earnings per share. Analysts anticipate that ICU Medical will post 3.76 earnings per share for the current year.</p>
<div class="lb-trans"><p>ICU Medical (納斯達克股票代碼:ICUI) 在 8 月 7 日星期三發佈了其最新的財報。這家醫療器械供應商報告稱，該季度每股收益為 1.56 美元，超過分析師預期的 1.00 美元 0.56 美元。該季度營收為 5.965 億美元，超過市場預期的 5.5664 億美元。ICU Medical 的淨利潤率為-3.07%，股東權益回報率為 5.01%。公司當季營收同比增長了 8.6%。在去年同期，公司每股收益為 1.58 美元。分析師預計 ICU Medical 今年將實現每股盈利 3.76 美元。</p>
</div><h2>About ICU Medical (Get Free Report)</h2>
<div class="lb-trans"><h2>關於 ICU Medical（獲取免費報告）</h2>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU 醫療公司及其子公司在全球範圍內開發、製造和銷售用於輸液治療、血管通路和重要護理應用的醫療器械。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢裝置；ChemoClave 和 ChemoLock 封閉系統轉移裝置，用於限制有害藥物或蒸氣濃度的泄漏，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 用於門靜脈通路的非穿刺針；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Read More</h2>
<ul>
<li>Five stocks we like better than ICU Medical</li>
<li>Election Stocks: How Elections Affect the Stock Market</li>
<li>Simon Property REIT: A Safe Bet for Growth and Steady Dividends</li>
<li>How to Know Which Cryptocurrency to Buy: A Guide for Investors</li>
<li>CarMax’s Impressive Rally: What Investors Should Watch Next</li>
<li>Which Wall Street Analysts are the Most Accurate?</li>
<li>MarketBeat Week in Review – 9/23 - 9/27</li>
</ul>
<div class="lb-trans"><h2>閲讀更多</h2>
<ul>
<li>我們喜歡的五隻股票勝過 ICU 醫療</li>
<li>選舉股票：選舉如何影響股市</li>
<li>西蒙地產房地產投資信託：增長和穩定股息的安全選擇</li>
<li>如何確定要購買哪種加密貨幣：投資者指南</li>
<li>CarMax 令人印象深刻的漲勢：投資者應該關注什麼</li>
<li>哪些華爾街分析師最準確？</li>
<li>MarketBeat 周評 – 9/23 - 9/27</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>這則即時新聞警報是由敍事科技和 MarketBeat 的金融數據生成，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊的審核。請將有關本故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><p>→ NOTICE: You have until Tuesday, November 19th (From Behind the Markets)(Ad)</p>
<div class="lb-trans"><p>→ 注意：您有時間直到 11 月 19 日星期二（來自市場幕後）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9780&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in ICU Medical right now?</h2>
<div class="lb-trans"><h2>您現在是否應該投資 1,000 美元購買 ICU 醫療股票？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮購買 ICU 醫療股票之前，您應該聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追蹤華爾街評級最高且表現最佳的研究分析師以及他們每天向客户推薦的股票。MarketBeat 已確定了五隻頂級分析師悄悄告訴客户現在購買的股票清單... 而 ICU 醫療並不在其中。</p>
</div><p>While ICU Medical currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 ICU 醫療目前在分析師中具有 “中等買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

ICU 醫療公司（納斯達克代碼：ICUI）的空頭頭寸下降了 10.1%